Bioresponsive drug delivery systems

Drug Discov Today. 2024 Jan;29(1):103849. doi: 10.1016/j.drudis.2023.103849. Epub 2023 Dec 3.

Abstract

In this review, we highlight the potential of stimuli-responsive drug delivery systems (DDSs) to revolutionize healthcare. Through examining pH, temperature, enzyme, and redox responsiveness, the presented case studies highlight the precision and enhanced therapeutic outcomes achievable with these innovative systems. Challenges, such as complex design and bio-based material optimization, underscore the complete journey from bench to bedside. Clinical strides in magnetically and temperature-responsive systems hint at a promising future for healthcare. However, overcoming issues of stability, durability, penetration depth, sensitivity, and active targeting is crucial. The future envisions theranostic systems, amalgamating targeted therapy and diagnosis, for personalized healthcare. Bio-based materials emerge as pivotal, offering a nuanced approach to complex diseases, such as cancer and diabetes, reshaping the healthcare landscape.

Keywords: bio-based materials; controlled drug release; nanoparticles; smart drug delivery systems; stimuli-responsive drug delivery systems.

Publication types

  • Review

MeSH terms

  • Drug Carriers / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Precision Medicine
  • Temperature

Substances

  • Drug Carriers